| CPC A61B 17/07207 (2013.01) [A61B 17/068 (2013.01); A61B 17/0684 (2013.01); A61B 17/072 (2013.01); A61B 17/320092 (2013.01); A61B 18/1445 (2013.01); A61B 34/30 (2016.02); G16H 40/63 (2018.01); H02K 7/116 (2013.01); H02K 7/145 (2013.01); A61B 2017/00017 (2013.01); A61B 2017/00022 (2013.01); A61B 2017/00039 (2013.01); A61B 2017/00075 (2013.01); A61B 2017/00132 (2013.01); A61B 2017/00185 (2013.01); A61B 2017/0019 (2013.01); A61B 2017/00221 (2013.01); A61B 2017/00398 (2013.01); A61B 2017/07257 (2013.01); A61B 2017/07271 (2013.01); A61B 2017/07278 (2013.01); A61B 2017/07285 (2013.01); A61B 2017/2932 (2013.01); A61B 2017/320074 (2017.08); A61B 2018/00642 (2013.01); A61B 2018/0072 (2013.01); A61B 2034/2059 (2016.02); A61B 2090/064 (2016.02)] | 20 Claims |

|
1. A surgical system comprising:
an end effector configured to grasp tissue and provide therapeutic treatment to tissue;
a motor configured to power one or more operations of the end effector;
a motor drive circuit configured to control power provided to the motor; and
a motor control circuit configured to:
provide a motor drive signal to the motor drive circuit, the motor drive signal being a default control for the therapeutic treatment of the tissue, and
adaptively control elements of the motor drive circuit to control deceleration of the motor in the absence of the motor drive signal.
|